Project description
A novel vaccine 'train' carries a diversely qualified team to the station
Vaccines are currently being made by tacking a natural antigen – a component of the offending microbe recognised by the immune system – onto a carrier protein. While this method has achieved significant gains in the realm of public health, the vaccines are rather limited in scope/function, and the current large protein molecule formulations have limited stability and shelf life. Sort of like a building manager with a lot of keys on their key ring, the EU-funded SUPRAVACC project's synthetic multipotent vaccines will carry multiple different immunostimulants and antigens. Their stability will get a boost from the reliance on small molecules rather than large delicate proteins. In short, the technology could revolutionise vaccine scope and vaccination speed and efficacy.
Fields of science
Call for proposal
ERC-2018-COG
See other projects for this call
Funding Scheme
ERC-COG - Consolidator Grant
Host institution
55122 Mainz
Germany
Beneficiaries (1)
55122 Mainz